Respiratory Flashcards

(81 cards)

1
Q

FEV1/FVC cut off for COPD

A

<0.7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chronic bronchitis definition

A

daily sputum production for at least 3 months of 2 or more consecutive years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What FEV1 chances to consider asthma or coexisting asthma and COPD

A

FEV1 increases >400mL following bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What imaging modality if better to detect PEs in COPD

A

CTPAs. VQ scans may be difficult to interpret in COPD patients because regional lung ventilation may be compromised leading to matched defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SABA/SAMA combinations in COPD

A

Provides additional benefits compared to using SAMA alone and decreased need for corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GOLD ABCD

A

A - mMRC 0-1 and 0-1 moderate/severe exacerbation (not leading to hospital admission) B - mMRC 2 or more, 0-1 mod/severe exacerbation C - mMRC 0-1 and 1 or more mod/severe leading to hospital admission or 2 or more mod/severe exacerbation D - more than above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GOLD A management

A

A bronchodilator of any type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GOLD B management

A

LABA or LAMA If persistent symptoms then combination LAMA/LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GOLD C management

A

LAMA If further exacerbations, LAMA+LABA combination or LABA + ICS combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GOLD D management

A

LAMA ->LAMA+LABA -> LABA + ICS -> LAMA + LABA + ICS Finally if further exacerbations: consider roflumilast if FEV1 <50% predicted and patient has chronic bronchitis Consider macrolide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pneumococcal vaccination for <65 COPD

A

PPSV23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How many generations of airways between the trachea and alveoli

A

23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how to distinguish between inflammation vs persistent airway remodeling components of airway hyperresponsiveness

A

Indirect and direct challenges. Indirect challenges are mannitol, hypertonic saline, eucapnic voluntary hyperventilation, exercise challenge, adenosine monophosphate- to active mast cells to release histamine and other bronchoconstrictor mediators Direct challenges is with methacholine - to directly constrict airway smooth muscle via receptors on smooth muscle Inflammatory component of AHR has greater responsiveness to indirect stimuli and persistent airway remodeling is more responsive to direct stimuli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Asthma step up therapy for controllers

A

Low dose ICS -> low dose ICS/LABA -> med/high dose ICS/LABA -> add on treatment (e.g. anti IgE, tiotropium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most effective strategy of reducing progression in COPD

A

Smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Light’s criteria

A

Exudate - at least one of: - ratio of pleural fluid protein to serum protein of >0.5 - ratio of pleural fluid LDH to serum LDH of >0.6 - Pleural fluid LDH >2/3 upper limit of normal serum LDH Increased false positive with people on diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Most likely cause of transudative pleural effusion

A

cardiac failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How to confirm diagnosis of heart failure as the cause of pleural effusion?

A

NT-proBNP >1500 pg/mL (+ve LR 15.2; neg LR 0.06)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Best pleural fluid test for diagnosis of pleural mycobacterium tuberculosis

A

Adenosine deaminase >50 U/L (sensitivity 95%, specificity 89%) Also as lymphocytes >50% normally Gold standard for TB diagnosis is thoracoscopy histology and AFB stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Biomarkers in malignant pleural effusion (tumour biomarkers and mesothelioma)

A

Tumours: CEA, CYFRA 21-1, CA 15-3 Mesothelioma: Mesothelin, fibulin 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the predictors of mortality in a pleural infection

A

Urea, age, prulence of fluid, infection source (CAP vs HAP), albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Indication of ICC insertion in pleural infection without preceding trial of antibiotics

A

pH < 7.2 Macroscopically purulent or gram stain/culture positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is a treatment option in patients with a pleural infection who has failed initial ICC/antibiotic treatment and is not suitable for VATS/surgery

A

Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNAse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how does pleural fluid pH need to be fun?

A

<1hr on a pH analyser for accuracy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Central sleep apnoea
26
What AHI (apnoea-hypopnea index) is normal?
\<5 | (per hour)
27
What AHI (apnoea and hypopnoea index) constitutes severe OSA
\>30
28
# based on AHI Clinical diagnosis of OSA
* AHI\>5/hr plus one symptom attributable to OSA (eg. daytime sleepiness, snoring, choking, mood disorder, HT, etc * AHI \>15/hr
29
what does use of CPAP in sleep apnoea reduce?
Blood pressure +/- stroke **Background:** There is RCT level studies demonstrating reduction in BP with CPAP. In 2016 (after this question was written) SAVE study demonstrated no reduction in AMI but ?reduction in stroke. CPAP use actually increases weight (because of reduced WOB), not sure about HF.
30
1. Variable intra-thoracic upper airway obstruction 2. Variable extra-thoracic upper airway obstruction Flattened inspiratory loop suggests extra thoracic obstruction
31
When is measuring total lung volumes clinically useful and which volumes are not measured during spirometry
Restrictive lung diseases TLC, FRC, RV
32
What lung volumes increases with age
Residual volume and funtional residual capacity
33
Anatomical airway vs physiological dead space
anatomical dead space is until the terminal bronchioles physiological dead space includes alveolar dead space from disease e.g. PE
34
indications for lytic therapy in PE
selected patients with acute PE not associated with hypotension and with a low risk of beeding but generally for hypotension who do not have a high risk of bleeding
35
When is O2 therapy indicated in COPD.
PaO2 \<55mmHg If PulHTN and polycythemia, then PaO2 \<60 mmHg Of note, the only thing that improves mortality benefit in COPD is oxygen therapy
36
Pulmonary function tests in pumonary vascular disease
low TLCO but everything else low
37
evidence for pulmonary rehabilitation exercise program
improve quality of life scores
38
evidence for nocturnal BPAP for chronic hypercapnia in COPD
evidence of mortality benefit https://jamanetwork.com/journals/jama/fullarticle/2627985
39
Factors that reduce TLCO
Abnormalities in the: * Gas exchange barrier * Emphysema * Thickening of membranes - ILD * Blood * PHT * Anaemia * Decrease in lung volume
40
How to distinguish between gas trapping and real restriction on lung volumes?
Real restriction: TLC \< LLN Gas trapping: RV/TLC \> ULN
41
KCO
TLCO/VA transfer coefficient Gas exchange per unit lung volume
42
Variable intrathoracic obstruction flow volume loop
43
reduction in both inspiratory and expiratory loops (flow volume loop)
Fixed upper airway obstruction — Firm tracheal lesions (eg, tracheal stenosis)
44
ILD quick desaturation
45
COPD
46
Cardiac dysfunction
47
What is the relationship of airway resistance to airway generation?
48
What is indirect and direct challenges of airway hyperresponsiveness
Indirect challenge: - Activates mast cells to release histamine and other bronchoconstrictors - E.g. mannitol, hypertonic saline, exrcise Direct challenge: - Directly constricts airway smooth muscle via receptors on smooth muscles - E.g. metacholine, histamine
49
Does indirect or direct cause detect inflammation more? Does indirect or direct cause detect airway remodelling more?
Inflammation - mannitol, hypertonic saline Persistent airway remodelling - direct challenge
50
Which out of the direct and indirect challenges for airway hyperresponsiveness is more sensitivite/specific?
Direct challenges are more sensitive Indirect challenges are more specific
51
Step up stages in asthma controller management
low dose ICS -\> low dose ICS/LABA -\> med/high ICS/LABA -\> add on tx (e.g. tiotropium, anti-IgE, anti-IL-5)
52
2x2 grid for GOLD ABCD classification
Y axis: exacerbation history (0/1 vs 2 or more or any leading to hospitalisation) X axis: mMRC 0-1 or mMRC 2 or more
53
Initial pharmacological management of stable COPD based on ABCD GOLD classification
54
Period of monitoring for solid vs sub-soild nodules as per Fleischner Society Guidelines
Solid \>6mm if stable after 2 years. STOP Subsolid \>6mm scan after 3-6 months for resolution. If stable after 5 years. STOP
55
Granulomatous interstitial lung disease
Sarcoid Hypersensitivity pneumonitis
56
Causes of UIP
– Idiopathic pulmonary fibrosis – Asbestosis – Connective tissue related ILD e.g. RA
57
Radiological features of UIP pattern (usual interstitial pneumonia)
- Apical basal gradient with bases being more affected - Reticulation - Traction bronchiectasis - Honeycombing - Architectural distortion Inconsistent features: - too much nodules, too much groundglass, too much moisac attenuation
58
What is the best pulmonary function test predictor of mortality for idiopathic pulmonary fibrosis
serial FVC trends
59
What is the most sensitive pulmonary function testing for change in interstitial lung disease when there is a mix of emphysema and fibrosis
Serial DLCO
60
most important function of BAL in the diagnostic evaluation of interstitial lung disease
to exclude chronic hypersensitivity pneumonitis (lymphocytic cellular pattern) should only be performed in selected patients
61
When should a lung biopsy be performed in the evaluation of interstitial lung disease?
Unclear for UIP pattern on chest HRCT to look for alternative diagnosis
62
What are the adverse effects of Pirfenidone?
photosensitivity, nausea, rash, diarrhoea
63
nintedanib MOA
An intracellular inhibitor that targets multiple tyrosine kinases
64
Nintedanib SE
GI upset, diarrhoea, nausea
65
NSIP radiology features
ground-glass opacities w basal predominance or diffuse subspleural sparing is a specific feature honeycombing is not a major feature there is traction bronchiectasis
66
What conditions are associated with NSIP
Connective tissue disease
67
When to use radial EBUS vs linear EBUS
radial EBUS for peripheral lesions Linear EBUS for peribronchial/peritracheal/mediastinal lesions
68
risk of death as a result of bronchoscopy
1/2500
69
What is the most common type of mutation in NSCLC
KRAS
70
difference between OSA and obesity hypoventilation syndrome on sleep study oximetry
OHS has prolonged hypoxia that doesn't resolve
71
maintenance of wakefulness test
measures ability to stay awake - e.g. measure of response to treatment
72
silicosis imaging findings
- nodules in upper zones - eggshell calcification
73
what infectious disease is associated with silicosis
2-30x risk of tuberculosis
74
PFT changes that indicate progressive disease in ILD
\>10% FVC \>15% DLCO
75
hypersensitivity pneumonitis CT findings
mosaic attenuation: hypoattenuation and hypovascularity of scattered secondary lobules: hypoattenuating regions that persist on expiratory CT scans are indicative of air trapping, which is caused by bronchiolar inflammation and obstruction
76
what population of people get lymphangioleiomyomatosis (LAM)
women of child-bearing age or people with tuberous sclerosis
77
When to do spirometry for COPD (inpatient vs outpatient)
Timing generally does not influence diagnosis
78
What is the strongest predictor of future COPD exacerabtion?
Exacerbation in the previous year
79
Evidence for pulmonary rehabilitation in COPD
Improvement in QOL Decrease in hospitalisations No change in mortality
80
Role of prophylactic antibiotics in COPD
Macrolides x 3 /week prevents hospitalisation Moxifloxacin/doxycycline doesn't work Doesn't work in smokers Not available on PBS for long term use Target patients: otherwise optimised, cough/sputum
81